Image
Current Studies
Join a Study
Menu

Condition: Atrial Fibrillation

A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke (OCEANIC-AF)

Location(s): St. Augustine

Condition: Atrial Fibrillation, Heart Disease

View Study Details
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76) (LILAC-TIMI 76)

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

Location(s): St. Augustine

Condition: Atrial Fibrillation, Heart Disease

View Study Details

Join Our Newsletter!

  • This field is for validation purposes and should be left unchanged.

Follow Us

Site Links

  • Home
  • About Us
  • Patients
  • Sponsors
  • Current Studies
  • Locations
  • Contact Us

Information

  • Register for Clinical Trial
  • Publications
  • Careers
  • Terms & Conditions
  • Privacy Policy
©TEXT East Coast Institute for Research, INC. All Rights Reserved.
  • About
  • Management Team
  • Patients
  • Sponsors
  • Current Studies
  • Fellowship
  • Locations
  • Compliance / Regulatory Team
  • Recruitment Team
  • Contact
  • Careers